JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Identification of Genes Differentially Expressed in the MCF-7 Cells Treated with Mitogenic Estrogens
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Identification of Genes Differentially Expressed in the MCF-7 Cells Treated with Mitogenic Estrogens
Cheon, Myeong-Sook; Yoon, Tae-Sook; Lee, Do-Yeon; Choi, Go-Ya; Lee, A-Yeong; Choo, Byung-Kil; Kim, Ho-Kyoung;
  PDF(new window)
 Abstract
Estrogens, a group of steroid compounds functioning as the primary female sex hormone, play an important role in the development and progression of breast cancer. In this study, using a novel annealing control primer-based GeneFishing PCR technology, five differentially expressed genes (DEGs), expressed using 10nM mitogenic estrogens, -estradiol (E2) and -hydroxyestrone (-OHE1), were selected from the estrogen receptor (ER)-positive MCF-7 human breast cancer cells. The DEGs, MRPL42, TUBA1B, SSBP1, KNCT2, and RUVBL1, were identified by comparison with the known genes via direct sequencing and sequence homology search in BLAST. Quantitative real-time PCR data showed that two DEGs, tubulin and kinetochore associated 2, were greater than 2-fold upregulated by E2 or -OHE1. Both genes could be new biomarkers for the treatment and prognosis of cancers, and further study may provide insights into the molecular mechanisms underlying development and progression of breast cancer.
 Keywords
differentially expressed genes-estradiol;estrogen receptor-positive MCF-7 human breast cancer cells-hydroxyestrone;kinetochore associated 2;tubulin ;
 Language
English
 Cited by
1.
Development of Media for the Cultivation of Enterobacter amnigenus GG0461 and its Nitrate Uptake, Journal of Applied Biological Chemistry, 2011, 54, 4, 252  crossref(new windwow)
 References
1.
Banerjee A (2002) Increased levels of tyrosinated $\alpha$-, $\beta$(III)-, and $\beta$(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun 293, 598-601 crossref(new window)

2.
Clemons M and Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344, 276-285 crossref(new window)

3.
Darbre P, Yates J, Curtis S, and King RJ (1983) Effect of estradiol on human breast cancer cells in culture. Cancer Res 43, 349-354

4.
Delmas PD (1997) Hormone replacement therapy in the prevention and treatment of osteoporosis. Osteoporos Int Suppl 1, S3-7

5.
DeLuca JG, Gall WE, Ciferri C, Cimini D, Musacchio A, and Salmon ED (2006) Kinetochore microtubule dynamics and attachment stability are regulated by Hec1. Cell 127, 969-982 crossref(new window)

6.
Ernst M, Schmid C, and Froesch ER (1989) Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. Steroid Biochem 33, 907-914 crossref(new window)

7.
Fishman J and Martucci C (1980) Biological properties of 16$\alpha$-hydroxyestrone: implications in estrogen physiology and pathophysiology. Clin Endocrinol Metab 51, 611-615 crossref(new window)

8.
Fishman J, Schneider J, Hershcope RJ, and Bradlow HL (1984) Increased estrogen-16$\alpha$-hydroxylase activity in women with breast and endometrial cancer. Steroid Biochem 20, 1077-1081 crossref(new window)

9.
Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, and Wenger N; HERS Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 288, 49-57 crossref(new window)

10.
Gupta M, McDougal A, and Safe S (1998) Estrogenic and antiestrogenic activities of 16$\alpha$- and 2-hydroxy metabolites of 17$\beta$-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 67, 413-419 crossref(new window)

11.
Hayama S, Daigo Y, Kato T, Ishikawa N, Yamabuki T, Miyamoto M, Ito T, Tsuchiya E, Kondo S, and Nakamura Y (2006) Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res 66, 10339-10348 crossref(new window)

12.
Hwang KC, Cui XS, Park SP, Shin MR, Park SY, Kim EY, and Kim NH (2004) Identification of differentially regulated genes in bovine blastocysts using an annealing control primer system. Mol Reprod Dev 69, 43-51 crossref(new window)

13.
Kim SH, Lee SU, Kim MH, Kim BT, and Min YK (2005) Mitogenic estrogen metabolites alter the expression of 17$\beta$-estradiol-regulated proteins including heat shock proteins in human MCF-7 breast cancer cells. Mol Cells 20, 378-384

14.
Kim YJ, Kwak CI, Gu YY, Hwang IT, and Chun JY (2004) Annealing control primer system for identification of differentially expressed genes on agarose gels. BioTechniques 36, 424-426, 428, 430 passim

15.
Lee EA, Keutmann MK, Dowling ML, Harris E, Chan G, and Kao GD (2004) Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol Cancer Ther 3, 661-669

16.
Lewis JS, Thomas TJ, Klinge CM, Gallo MA, and Thomas T (2001) Regulation of cell cycle and cyclins by 16$\alpha$- hydroxyestrone in MCF-7 breast cancer cells. J Mol Endocrinol 27, 293-307 crossref(new window)

17.
Li L, Yang L, Scudiero DA, Miller SA, Yu ZX, Stukenberg PT, Shoemaker RH, and Kotin RM (2007) Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells. Gene Ther 14, 817-824

18.
Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the $2^{{-\Delta}{\Delta}CT}$ method. Methods 25, 402-408 crossref(new window)

19.
Martin-Lluesma S, Stucke VM, and Nigg EA (2002) Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 297, 2267-2270 crossref(new window)

20.
McGuire WL, Horwitz KB, Chamness GC, and Zava DT (1976) A physiological role for estrogen and progesterone in breast cancer. J Steroid Biochem 7, 875-882 crossref(new window)

21.
Rozen S and Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S and Misener S. pp. 365-386, Humana Press. Totowa, NJ

22.
Ryu JY, Lee BM, Kacew S, and Kim HS (2007) Identification of differentially expressed genes in the testis of Sprague-Dawley rats treated with di(n-butyl) phthalate. Toxicology 234, 103-112 crossref(new window)

23.
Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, Itoh A, Funata N, Schreiber SL, Yoshida M, and Toi M (2005) Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene 24, 4531-4539 crossref(new window)

24.
Schneider J. Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, and Fishman J (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79, 3047-3051

25.
Sengupta S and Thomas SA (2006) Drug target interaction of tubulin-binding drugs in cancer therapy. Expert Rev Anticancer Ther 6, 1433-1447 crossref(new window)

26.
Swaneck GE and Fishman J (1988) Covalent binding of the endogenous estrogen 16$\alpha$-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA 85, 7831-7835